Literature DB >> 2367328

Pharmaceutical usefulness of hydroxypropylcyclodextrins: "e pluribus unum" is an essential feature.

C T Rao1, H M Fales, J Pitha.   

Abstract

A series of hydroxypropyl-beta-cyclodextrins was prepared by a method that leads to a preferential substitution on the secondary hydroxyls, mainly O-2, of beta-cyclodextrin with (S)-2-hydroxypropyl groups. The series consisted of mixtures of compounds with average degrees of substitution of 8, 3, and 1.6 and of a specially isolated monosubstituted compound; thus, the number of components progressively decreased in this series. The crystallinity in the series increased progressively, the first member being fully amorphous and the last one fully crystalline. All members of the series formed clear aqueous solutions at concentrations of greater than 50.0, 2.0, 0.6, and 0.3%, respectively. Therefore, pharmaceutically useful hydroxypropylcyclodextrin preparations are those containing a large number of chemically individual compounds--a feature resulting in an amorphous state and high water solubility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2367328     DOI: 10.1023/a:1015818211518

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.

Authors:  J Pitha; J Pitha
Journal:  J Pharm Sci       Date:  1985-09       Impact factor: 3.534

2.  Hydroxypropyl-beta-cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity.

Authors:  B W Müller; U Brauns
Journal:  J Pharm Sci       Date:  1986-06       Impact factor: 3.534

Review 3.  Cyclodextrins in drug carrier systems.

Authors:  K Uekama; M Otagiri
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

4.  Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones.

Authors:  J Pitha; S M Harman; M E Michel
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

5.  Change of phase-solubility behavior by gamma-cyclodextrin derivatization.

Authors:  B W Müller; U Brauns
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.